NCT02768766 2023-08-31Intermittent Selumetinib for Uveal MelanomaColumbia UniversityPhase 1 Completed42 enrolled
NCT01143402 2017-07-26Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the EyeNational Cancer Institute (NCI)Phase 2 Completed120 enrolled 8 charts